BioCer to showcase plant-based hemostasis and coated hernia repair technologies to China.

BioCer Entwicklungs GmbH, a Bayreuth, Germany based medical device manufacturer, has announced their attendance at the China Medical Equipment Fair (CMEF) Shenzhen, China 15^th-19^th April 2011. HaemoCer™ an Absorbable Polysaccharide Hemostat (APH) and Ti0²Mesh™ Hernia repair system will be on exhibit at the BioCer booth.

HaemoCer™ APH technology is delivered in a powder format developed to meet the challenges of problematic bleeding in surgery. Utilizing Biocer’s Polysacharide Ultra-hydrophilic Resorbable Engineering (PURE) process modifies plant-based polymers to create a highly absorptive, biocompatible agent which enhances and accelerates the natural clotting cascade. The PURE technology format of HaemoCer™ APH contains no thrombin, collagen, or other human or animal components, and is resorbed within days.

TiO₂Mesh™ is an implant utilizing a biocompatible coating for surgical Hernia repair. Ti0²Mesh™ combines multiple requirements, specifically addressing the needs of the laparoscopic surgeon. TiO₂Mesh™ offers a complete solution to the laparoscopic surgeon and coincides with the advance and rapid growth of minimally invasive surgery in China.

Heinz-Josef Schmies, Managing Director of BioCer Entwicklungs Gmbh commented, “The introduction at the CMEF of HaemoCer™ APH and its proprietary, integrated PURE technology offers Asian-Pacific medical professionals an opportunity to examine directly the latest advance in polysaccharide hemostats. TiO₂Mesh™ which encompasses a cutting edge coating technology combined with all the requirements of the ideal Hernia repair mesh offers a complete solution to unmet needs. We anticipate surgeons and patients in China and Asia-Pacific will benefit from these advanced technological innovations in Hernia repair and Hemostasis. "

BioCer Entwicklungs GmbH is a privately-held medical device company and welcomes CMEF visitors to their booth H26, hall 2. For further information, distribution inquiries, and licensing options, please visit http://www.biocer-gmbh.de/en/.